Terug
Dagbereik
€ 50,48
€ 51,68
52-Weeksbereik
€ 38,39
€ 51,68
Volume
19.975.306
50D / 200D Gem.
€ 46,25
/
€ 43,05
Vorige Slotkoers
€ 50,58
Koershistorie
Financiële Trends
Sectorvergelijking
vs Communication Services sector mediaan (238 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 12,5 | 5,8 |
| P/B | 2,1 | 1,3 |
| ROE % | 16,9 | 9,3 |
| Net Margin % | 12,4 | 6,4 |
| Rev Growth 5Y % | 0,9 | 5,1 |
| D/E | 1,9 | 0,7 |
Koersdoel Analisten
Hold
€ 50,14
-1.5%
Low: € 44,00
High: € 58,00
Forward K/W
10,3
Forward WPA
€ 4,91
WPA Groei (sch.)
+0,0%
Omzet Sch.
140 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 6,97
€ 6,78 – € 7,16
|
150 B | 6 |
| FY2029 |
€ 6,04
€ 5,87 – € 6,21
|
150 B | 6 |
| FY2028 |
€ 5,69
€ 5,16 – € 6,12
|
150 B | 8 |
Insider Trading Activity
19 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 12, 2026 |
Villanueva Rodriguez Alfonso
EVP&Int.Group CEO-VZ Cons.&CTO
|
grant | 72 | € 14,44 | € 1.040 |
| Feb 26, 2026 |
Malady Kyle
EVP and Group CEO-VZ Business
|
grant | 7.223 | € 13,95 | € 100.761 |
| Jan 15, 2026 |
Malady Kyle
EVP and Group CEO-VZ Business
|
grant | 155 | € 11,24 | € 1.742 |
| Jan 15, 2026 |
Sampath Sowmyanarayan
EVP and Group CEO-VZ Consumer
|
grant | 175 | € 11,24 | € 1.967 |
| Dec 31, 2025 |
Malady Kyle
EVP and Group CEO-VZ Business
|
grant | 150 | € 11,63 | € 1.745 |
| Dec 4, 2025 |
Malady Kyle
EVP and Group CEO-VZ Business
|
grant | 147 | € 11,78 | € 1.732 |
| Nov 6, 2025 |
Sampath Sowmyanarayan
EVP and Group CEO-VZ Consumer
|
grant | 173 | € 11,37 | € 1.967 |
| Nov 6, 2025 |
Malady Kyle
EVP and Group CEO-VZ Business
|
grant | 152 | € 11,37 | € 1.728 |
| Oct 9, 2025 |
Sampath Sowmyanarayan
EVP and Group CEO-VZ Consumer
|
grant | 168 | € 11,66 | € 1.959 |
| Oct 9, 2025 |
Malady Kyle
EVP and Group CEO-VZ Business
|
grant | 148 | € 11,66 | € 1.726 |
| Sep 25, 2025 |
Sampath Sowmyanarayan
EVP and Group CEO-VZ Consumer
|
grant | 159 | € 12,37 | € 1.967 |
| Jul 31, 2025 |
Sampath Sowmyanarayan
EVP and Group CEO-VZ Consumer
|
grant | 161 | € 12,20 | € 1.964 |
| Jul 2, 2025 |
Malady Kyle
EVP and Group CEO-VZ Business
|
grant | 139 | € 12,44 | € 1.729 |
| Jun 18, 2025 |
Sampath Sowmyanarayan
EVP and Group CEO-VZ Consumer
|
grant | 165 | € 11,89 | € 1.962 |
| Jun 5, 2025 |
Sampath Sowmyanarayan
EVP and Group CEO-VZ Consumer
|
grant | 159 | € 12,35 | € 1.964 |
| May 22, 2025 |
Sampath Sowmyanarayan
EVP and Group CEO-VZ Consumer
|
grant | 159 | € 12,31 | € 1.957 |
| Apr 30, 2025 |
Malady Kyle
EVP and Group CEO-VZ Business
|
sell | 7.500 | € 43,88 | € 329.063 |
| Apr 23, 2025 |
Malady Kyle
EVP and Group CEO-VZ Business
|
sell | 5.000 | € 42,49 | € 212.425 |
| Mar 27, 2025 |
Malady Kyle
EVP and Group CEO-VZ Business
|
grant | 135 | € 12,82 | € 1.731 |
Belangrijkste Punten
Revenue grew 0,85% annually over 5 years — modest growth
ROE of 16,86% — decent returns on equity
Generating 20,13B in free cash flow
P/E of 12,50 — trading at a low valuation
Cash machine — converts 117,19% of earnings into free cash flow
Groei
Revenue Growth (5Y)
0,85%
Revenue (1Y)2,52%
Earnings (1Y)-1,90%
FCF Growth (3Y)3,72%
Kwaliteit
Return on Equity
16,86%
ROIC7,19%
Net Margin12,43%
Op. Margin21,17%
Veiligheid
Debt / Equity
1,92
Current Ratio0,91
Interest Coverage4,37
Waardering
P/E Ratio
12,50
P/B Ratio2,06
EV/EBITDA13,54
Dividend Yield0,07%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2,52% | Revenue Growth (3Y) | 1,56% |
| Earnings Growth (1Y) | -1,90% | Earnings Growth (3Y) | 21,60% |
| Revenue Growth (5Y) | 0,85% | Earnings Growth (5Y) | -6,07% |
| Profitability | |||
| Revenue (TTM) | 138,19B | Net Income (TTM) | 17,17B |
| ROE | 16,86% | ROA | 4,25% |
| Gross Margin | 45,64% | Operating Margin | 21,17% |
| Net Margin | 12,43% | Free Cash Flow (TTM) | 20,13B |
| ROIC | 7,19% | FCF Growth (3Y) | 3,72% |
| Safety | |||
| Debt / Equity | 1,92 | Current Ratio | 0,91 |
| Interest Coverage | 4,37 | Dividend Yield | 0,07% |
| Valuation | |||
| P/E Ratio | 12,50 | P/B Ratio | 2,06 |
| P/S Ratio | 1,55 | PEG Ratio | -4,62 |
| EV/EBITDA | 13,54 | Dividend Yield | 0,07% |
| Market Cap | 214,72B | Enterprise Value | 396,27B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 138,19B | 134,79B | 133,97B | 136,84B | 133,61B |
| Net Income | 17,17B | 17,51B | 11,61B | 21,26B | 22,07B |
| EPS (Diluted) | 4,06 | 4,15 | 2,75 | 5,06 | 5,32 |
| Gross Profit | 63,08B | 62,80B | 61,46B | 60,60B | 61,11B |
| Operating Income | 29,26B | 30,60B | 28,83B | 30,47B | 31,97B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 404,26B | 384,71B | 380,26B | 379,68B | 366,60B |
| Total Liabilities | 298,52B | 284,14B | 286,46B | 287,22B | 283,40B |
| Shareholders' Equity | 104,46B | 99,24B | 92,43B | 91,14B | 81,79B |
| Total Debt | 200,59B | 168,36B | 174,94B | 176,33B | 177,93B |
| Cash & Equivalents | 19,05B | 4,19B | 2,07B | 2,61B | 2,92B |
| Current Assets | 56,92B | 40,52B | 36,81B | 37,86B | 36,73B |
| Current Liabilities | 62,37B | 64,77B | 53,22B | 50,17B | 47,16B |